Literature DB >> 31313317

Prescribers' views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: A survey in remote and rural Scotland.

Daria Generalova1, Scott Cunningham1, Stephen J Leslie2, Gordon Rushworth3, Laura McIver4, Derek Stewart5.   

Abstract

AIMS: A recent systematic review highlighted the lack of robust studies on prescribers' perspectives of direct-acting oral anticoagulants (DOACs) for nonvalvular atrial fibrillation. The aim was to determine prescribers' views and experiences of prescribing DOACs.
METHODS: A cross-sectional survey of prescribers in a remote and rural area of Scotland. Survey items were: demographics; prescribing of DOACs; views of potential influences on DOAC prescribing; knowledge of prescribing guidelines; and experiences. Items on potential influences were based on the Theoretical Domains Framework. Data were analysed using descriptive and inferential statistics, and content analysis of responses to open questions. Principal component analysis was performed on the items of potential influences.
RESULTS: In total, 154 responses were received, 120 (77.9%) from doctors, 18 (11.7%) from nurse prescribers and 10 (6.4%) from pharmacist prescribers (6 missing). Principal component analysis of the Theoretical Domains Framework items of potential influences gave 4 components. Component scores for (i) role of professionals, their knowledge and skills and (ii) influences on prescribing were positive. Those for (iii) consequences of prescribing and (iv) monitoring for safety and effectiveness were more neutral. There were low levels of agreement for statements relating to DOACs being more effective, safer and cost-effective than warfarin. There were similar responses around the complexity of bleeding management and detection of over and under-anticoagulation.
CONCLUSION: This study has identified several key issues of DOAC prescribing (e.g. bleeding management) hence further emphasis is required in continuing professional development and during guideline implementation and evaluation.
© 2019 The British Pharmacological Society.

Entities:  

Keywords:  drug utilization; prescribing; quality use of medicines

Mesh:

Substances:

Year:  2019        PMID: 31313317      PMCID: PMC6783578          DOI: 10.1111/bcp.14069

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  25 in total

1.  The use of theory in research.

Authors:  Derek Stewart; Susan Klein
Journal:  Int J Clin Pharm       Date:  2016-06

2.  The use of direct oral anticoagulants for stroke prevention in atrial fibrillation: a study on physicians' perspective and preferences.

Authors:  Alexander Wutzler; Marwin Bannehr; Ann Cathrin Pöhlmann; Wilhelm Haverkamp
Journal:  Int J Cardiol       Date:  2014-04-29       Impact factor: 4.164

3.  Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.

Authors:  Torben Bjerregaard Larsen; Tatjana Potpara; Nikolaos Dagres; Alessandro Proclemer; Elena Sciarrafia; Carina Blomström-Lundqvist
Journal:  Europace       Date:  2015-05       Impact factor: 5.214

4.  Prescribers' views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: A survey in remote and rural Scotland.

Authors:  Daria Generalova; Scott Cunningham; Stephen J Leslie; Gordon Rushworth; Laura McIver; Derek Stewart
Journal:  Br J Clin Pharmacol       Date:  2019-08-02       Impact factor: 4.335

5.  Trends in the prescription of novel oral anticoagulants in UK primary care.

Authors:  Simone Y Loo; Sophie Dell'Aniello; Laetitia Huiart; Christel Renoux
Journal:  Br J Clin Pharmacol       Date:  2017-05-04       Impact factor: 4.335

6.  Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.

Authors:  Laura J Damschroder; David C Aron; Rosalind E Keith; Susan R Kirsh; Jeffery A Alexander; Julie C Lowery
Journal:  Implement Sci       Date:  2009-08-07       Impact factor: 7.327

7.  Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention.

Authors:  Jason G Andrade; Andrew D Krahn; Allan C Skanes; Daniel Purdham; Antonio Ciaccia; Sean Connors
Journal:  Can J Cardiol       Date:  2015-11-10       Impact factor: 5.223

8.  Factors influencing doctors' selection of dabigatran in non-valvular atrial fibrillation.

Authors:  Cindy Huang; Michele Siu; Lily Vu; Soo Wong; Jaekyu Shin
Journal:  J Eval Clin Pract       Date:  2012-07-26       Impact factor: 2.431

Review 9.  Maximising response to postal questionnaires--a systematic review of randomised trials in health research.

Authors:  Rachel A Nakash; Jane L Hutton; Ellen C Jørstad-Stein; Simon Gates; Sarah E Lamb
Journal:  BMC Med Res Methodol       Date:  2006-02-23       Impact factor: 4.615

10.  Developing and evaluating complex interventions: the new Medical Research Council guidance.

Authors:  Peter Craig; Paul Dieppe; Sally Macintyre; Susan Michie; Irwin Nazareth; Mark Petticrew
Journal:  BMJ       Date:  2008-09-29
View more
  3 in total

1.  Prescribers' views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: A survey in remote and rural Scotland.

Authors:  Daria Generalova; Scott Cunningham; Stephen J Leslie; Gordon Rushworth; Laura McIver; Derek Stewart
Journal:  Br J Clin Pharmacol       Date:  2019-08-02       Impact factor: 4.335

2.  Prescribers' perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation.

Authors:  Daria Generalova; Scott Cunningham; Stephen J Leslie; Gordon F Rushworth; Laura Mciver; Derek Stewart
Journal:  Pharm Pract (Granada)       Date:  2020-06-13

3.  [Prescribing behavior of Bavarian general practitioners at the inpatient-outpatient interface within the context of the Bavarian active substance agreement-qualitative results of the WirtMed Study].

Authors:  Nikoletta Zeschick; Julia Gollnick; Julia Muth; Franziska Hörbrand; Peter Killian; Wolfgang Krombholz; Norbert Donner-Banzhoff; Thomas Kühlein; Maria Sebastião
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-07-15       Impact factor: 1.595

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.